-
Je něco špatně v tomto záznamu ?
Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL
B. Jancekova, E. Ondrouskova, L. Knopfova, J. Smarda, P. Benes,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
NT13441
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Medline Complete (EBSCOhost)
od 2005-01-01 do 2016-12-31
ROAD: Directory of Open Access Scholarly Resources
od 1987
- MeSH
- adenokarcinom enzymologie patologie MeSH
- aktivace enzymů MeSH
- apoptóza účinky léků MeSH
- chemorezistence MeSH
- endozomy metabolismus MeSH
- kaspasa 8 metabolismus MeSH
- kathepsin D antagonisté a inhibitory genetika fyziologie MeSH
- koncentrace vodíkových iontů MeSH
- lidé MeSH
- lyzozomy metabolismus MeSH
- malá interferující RNA genetika MeSH
- nádorové buněčné linie MeSH
- nádorové proteiny antagonisté a inhibitory genetika fyziologie MeSH
- nádory prsu enzymologie patologie MeSH
- protein Bid metabolismus MeSH
- protein TRAIL farmakologie MeSH
- protoonkogenní proteiny c-bcl-2 metabolismus MeSH
- rekombinantní proteiny metabolismus farmakologie MeSH
- RNA interference MeSH
- transfekce MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Cathepsin D (CD), a ubiquitously expressed lysosomal aspartic protease, is upregulated in human breast carcinoma and many other tumor types. CD has been repeatedly reported to act as key mediator of apoptosis induced by various chemotherapeutics. However, there is still controversy over the role of enzymatic/proteolytic versus protein-protein interaction activities of CD in apoptotic signaling. The elucidation of molecular mechanism responsible for the effect of CD in the chemotherapy-induced cell death is crucial for development of an appropriate strategy to target this protease in cancer treatment. Therefore, the objective of this study was to investigate the molecular mechanism behind the CD-mediated regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death. For this purpose, MDA-MB-231 breast carcinoma cells with an increased level of wt CD (CD) or mutant enzymatically inactive CD (ΔCD) were subjected to TRAIL and the frequency of apoptosis was determined. Our results show that CD facilitates the TRAIL-induced apoptosis of MDA-MB-231 breast cancer cells in enzymatic activity-dependent manner. Moreover, the importance of endosomal/lysosomal acidification in this process was documented. Analysis of the potential substrates specifically cleaved by CD during the TRAIL-induced apoptosis confirmed caspase-8 and Bid proteins as the CD targets. Moreover, in search for protein regulators of apoptosis that can be cleaved by CD at physiologically relevant pH, we identified the Bcl-2 protein as a suitable candidate. The modulatory role of CD in cell response to TRAIL was also confirmed in another breast cancer cell line SKBR3. These experiments identified the CD enzymatic activity as a new factor affecting sensitivity of breast cancer cells to TRAIL.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014099
- 003
- CZ-PrNML
- 005
- 20181114101023.0
- 007
- ta
- 008
- 170413s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13277-016-4958-5 $2 doi
- 035 __
- $a (PubMed)26867770
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jančeková, Blanka $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's, University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. $7 xx0282698
- 245 10
- $a Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL / $c B. Jancekova, E. Ondrouskova, L. Knopfova, J. Smarda, P. Benes,
- 520 9_
- $a Cathepsin D (CD), a ubiquitously expressed lysosomal aspartic protease, is upregulated in human breast carcinoma and many other tumor types. CD has been repeatedly reported to act as key mediator of apoptosis induced by various chemotherapeutics. However, there is still controversy over the role of enzymatic/proteolytic versus protein-protein interaction activities of CD in apoptotic signaling. The elucidation of molecular mechanism responsible for the effect of CD in the chemotherapy-induced cell death is crucial for development of an appropriate strategy to target this protease in cancer treatment. Therefore, the objective of this study was to investigate the molecular mechanism behind the CD-mediated regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death. For this purpose, MDA-MB-231 breast carcinoma cells with an increased level of wt CD (CD) or mutant enzymatically inactive CD (ΔCD) were subjected to TRAIL and the frequency of apoptosis was determined. Our results show that CD facilitates the TRAIL-induced apoptosis of MDA-MB-231 breast cancer cells in enzymatic activity-dependent manner. Moreover, the importance of endosomal/lysosomal acidification in this process was documented. Analysis of the potential substrates specifically cleaved by CD during the TRAIL-induced apoptosis confirmed caspase-8 and Bid proteins as the CD targets. Moreover, in search for protein regulators of apoptosis that can be cleaved by CD at physiologically relevant pH, we identified the Bcl-2 protein as a suitable candidate. The modulatory role of CD in cell response to TRAIL was also confirmed in another breast cancer cell line SKBR3. These experiments identified the CD enzymatic activity as a new factor affecting sensitivity of breast cancer cells to TRAIL.
- 650 _2
- $a adenokarcinom $x enzymologie $x patologie $7 D000230
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a protein Bid $x metabolismus $7 D051023
- 650 _2
- $a nádory prsu $x enzymologie $x patologie $7 D001943
- 650 _2
- $a kaspasa 8 $x metabolismus $7 D053181
- 650 _2
- $a kathepsin D $x antagonisté a inhibitory $x genetika $x fyziologie $7 D002402
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a chemorezistence $7 D019008
- 650 _2
- $a endozomy $x metabolismus $7 D011992
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a lyzozomy $x metabolismus $7 D008247
- 650 _2
- $a nádorové proteiny $x antagonisté a inhibitory $x genetika $x fyziologie $7 D009363
- 650 _2
- $a protoonkogenní proteiny c-bcl-2 $x metabolismus $7 D019253
- 650 _2
- $a RNA interference $7 D034622
- 650 _2
- $a malá interferující RNA $x genetika $7 D034741
- 650 _2
- $a rekombinantní proteiny $x metabolismus $x farmakologie $7 D011994
- 650 _2
- $a protein TRAIL $x farmakologie $7 D053221
- 650 _2
- $a transfekce $7 D014162
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ondroušková, Eva $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. Masaryk Memorial Cancer Institute, RECAMO, Zluty kopec 7, 656 53, Brno, Czech Republic. $7 _AN058804
- 700 1_
- $a Knopfová, Lucia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's, University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. $7 xx0208986
- 700 1_
- $a Šmarda, Jan, $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. $d 1961- $7 mzk2006343362
- 700 1_
- $a Beneš, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic. pbenes@sci.muni.cz. International Clinical Research Center, Center for Biological and Cellular Engineering, St. Anne's, University Hospital Brno, Pekarska 53, 656 91, Brno, Czech Republic. pbenes@sci.muni.cz. $7 xx0208982
- 773 0_
- $w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 8 (2016), s. 10685-96
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26867770 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20181114101109 $b ABA008
- 999 __
- $a ok $b bmc $g 1200564 $s 974877
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 37 $c 8 $d 10685-96 $e 20160211 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
- GRA __
- $a NT13441 $p MZ0
- LZP __
- $a Pubmed-20170413